# Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

> **NCT05975151** · PHASE2 · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 63 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Pseudomonas aeruginosa

## Key facts

- **NCT ID:** NCT05975151
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05975151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05975151, "Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05975151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*